Skip to main content
Fig. 3 | Journal of Ovarian Research

Fig. 3

From: Platelet count as a biomarker for monitoring treatment response and disease recurrence in recurrent epithelial ovarian cancer

Fig. 3

a Apoptosis rates of SKOV-3 co-cultured with platelets 0.5 × 108/mL,1 × 10^8/mL,2 × 108/mL,4 × 108/mL compared to serum free media; b With the addition of 5 nM docetaxel, apoptosis rates of SKOV-3 co-cultured with platelets 0.5 × 108/mL,1 × 10^8/mL,2 × 108/mL,4 × 108/mL compared to only 5 nM docetaxel; c SKOV-3 co-cultured with platelets 0.5 × 108/mL,1 × 108/mL,2 × 108/mL,4 × 108/mL, platelets decreased apoptosis from 15.7 to 7.0%(p = 0.01),6.3%(p = 0.008),8.8%(p = 0.044),14.4%(p = 0.706) compared to serum free media respectively; d With the addition of 5 nM docetaxel, platelets 0.5 × 108/mL,1 × 108/mL,2 × 108/mL,4 × 108/mL decreased apoptosis from 61.9 to 43.2%(p = 0.03),38.6% (p = 0.015),48.6%(p = 0.098),51.1% (p = 0.26) compared to only 5 nM docetaxel respectively

Back to article page
\